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Abstract: Quantitative microbial risk assessment (QMRA) is a relatively new approach in identifying
health risks associated with the ubiquitous presence of pathogens and opportunists in the human
environment. The methodology builds on experimental and meta-analytical data to identify
measurable factors that contribute to, and can quantify, the likely extent of disease given a particular
exposure. Early modelling was particularly focused on food-borne disease, and subsequently
water-borne disease, with the emphasis focused on ingestion and its role in enteric disease. More
recently, there has been a focus on translating these principles to opportunist waterborne infections
(OWI) with primary focus on Legionella spp. Whereas dose and susceptibility are well documented
via the ingestion route of exposure there is considerably less certainty regarding both factors when
understanding Legionella spp. and other OWI. Many OWI can arise through numerous routes of
transmission with greatly differing disease presentations. Routes of Legionella spp. infection do
not include ingestion, but rather aspiration and inhalation of contaminated water are the routes of
exposure. The susceptible population for OWI is a vulnerable sub-set of the population unlike those
associated with enteric disease pathogens. These variabilities in dose, exposure and susceptibility
call in to question whether QMRA can be a useful tool in managing risks associated with OWI.
Consideration of Legionella spp. as a well-documented subject of research calls into question whether
QMRA of OWI is likely to be a useful tool in developing risk management strategies.
Keywords: opportunistic pathogens; QMRA; risk assessment; public health; manufactured water systems;
drinking water; Mycobacterium avium; Pseudomonas; non-tuberculous mycobacteria
1. Introduction
In the early 1990’s Quantitative Microbial Risk Assessment (QMRA) was developed as a tool
to understand the likely outcomes of microbial exposures in food [1,2]. This innovative approach
has been widely accepted as a major development in protecting public health. Subsequently, QMRA
became a useful tool in determining threshold limits for microbial contamination in manufactured
food products. More recently the QMRA principles were applied to potable water supplies [3,4].
QMRA were developed for a range of enteric bacterial and protozoan parasites in water distribution
systems. It is worthy of note that all of these useful developments were focused on the ingestion or
oral/fecal route as the primary mode of transmission [2,4]. It has been proposed that QRMA should
be developed for other opportunist waterborne infections (OWI) such as Mycobacterium avium and
Pseudomonas species in engineered (potable) water systems [5]. The stated overall objective of QMRA
is to inform health risk assessment and management practices.
QMRA relies on both laboratory and field data to identify an infection threshold. Infectious dose
is one significant element in the calculation. The number of organisms required to induce infection has
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been calculated from historical data and in many applications, is quite robust. In developing QMRA
the response of an exposed population has mostly (but not exclusively) been compiled from field data.
From these compiled data the likely morbidity and mortality of a given population can be predicted
given the exposure scenario, exposed demographic and ingestion. In terms of disease burden this
is commonly summarized as a Disability Adjusted Life Year (DALY). Factors used to make these
predictions include source of contamination, consumption, dose-response and frequency of exposure.
These factors can then be used to quantify the different stages of a risk assessment and a management
strategy [4,6].
Legionella spp. is a well characterized and researched organism that can serve as a representative
OWI. Clinical presentations of disease and routes of exposure for Legionella spp. infection are less
diverse than other OWI, such as Mycobacterium avium complex (MAC) [7]. This allows Legionella spp.
to be used as a simple model for consideration of QMRA as a useful risk management tool for other
OWI. The authors are not aware of published QMRA for other OWI in potable water systems.
Recently there have been attempts at developing a QMRA framework to quantify risks from
Legionella spp. contamination in potable water systems [8–11]. Research gaps in developing such
a framework have been identified [12,13]. These gaps include source of contamination, exposure
routes, dose-response and exposure assessment, variable host susceptibilities and uncertainties. Given
the uncertainty in all the factors used to develop a QMRA framework it is questionable whether
a meaningful model can be arrived at for contraction of Legionella spp. infections. The accepted
framework for water related QMRA is reproduced from the World Health Organization document [4]
and shown in Figure 1: This paper discusses the uncertainties surrounding these factors and their
potential for use in a meaningful QMRA for Legionella spp. infections and their implications for
other OWI.
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fever is an infection or not, and some evidence demonstrates that the syndrome is not limited purely
to Legionella spp. exposures [16,17].
3. Sources of Contamination
A wide range of different sources of Legionella spp. contamination have been identified. Cooling
towers, spa pools, and potable water systems are the most commonly identified sources [18]. However,
a recent systematic literature review conducted by van Heijnsbergen et al. [19] identified thirty other
potential sources including natural waters, medical respiratory equipment, construction activities, ice
machines and hoses. The European Working Group for Legionella spp. infections (EWGLI) (2017)
acknowledges that potable water and cooling towers are likely to contain low levels of Legionella. It is
recommended that a positive Legionella spp. detection less than 1000 CFU/L requires no response other
than to ensure biocide levels, temperatures etc are within targets. Whereas, positive detections above
1000 CFU/L in 80–90% of samples warrants a risk assessment to determine if remedial actions (including
disinfection) are required. The ubiquitous nature of Legionella spp. in the environment raises the question
as to why the number of Legionnaires disease cases are comparatively low. “ . . . one fundamental paradox of
legionellosis epidemiology is that if these microbes are environmentally abundant so that exposure must be almost
ubiquitous, why is disease uncommon? What are we missing?“ [20].
The diversity of sources also illustrates that the nature of their contamination is similarly diverse.
Water supply quality is often more controlled that water quality within buildings. Factors that play
an important role in Legionella spp. proliferation in manufactured water systems include temperature,
nutrients, flow rate and disinfectant residual [5]. These also influence biofilm formation which
is acknowledged as the principle multiplication point for Legionella spp. and other opportunist
pathogens. However, the nature of biofilm formation, extent, and location within the system is very
much determined by the source construction [18].
Variations in the water supply and quality are common both spatially and temporally. As water
quality has a known influence on microbial colonization, including Legionella, supply quality is
a critical parameter that is unpredictable even within a single source. Changes to supply water quality
have been identified as the single major contribution to elevated numbers of Legionnaires’ disease
cases in Flint (MI, USA) in 2016 [21].
Changes in the environmental conditions within a water supply can also result in a distinct shift
in Legionella spp. populations. This was highlighted by a study of hot and cold water samples collected
from a single potable water distribution system in Braunschweig (Germany). This study demonstrated
that the composition of Legionella spp. was distinctly different in the hot and cold water and this
difference was observed throughout a seasonal cycle [22]. It is worth noting that some sources are
associated with specific Legionella spp. and not others. For instance, outbreaks of disease associated
with cooling towers are almost exclusively confined to Legionella pneumophila serogroup 1 (SG1). Other
species of Legionella spp. tend to be associated with infections from devices and equipment associated
with high risk populations [18].
This diverse range of sources combined with a relatively long incubation period (1–21 days)
has led to considerable uncertainties in identifying either the source or the organism responsible
in outbreak scenarios [18]. For example, Legionella spp. may be detected in a suspected source
during an outbreak investigation but genotypical analysis may find it to be different to cause of the
outbreak [23]. Identifying outbreak sources is also complicated by the limitations of the culture method
of detection which does not detect viable but non-culturable Legionella, resulting in false negative test
results [24].
These combined factors mean that a single quantifiable or estimable source of contamination by
Legionella spp. is source specific and in some instances likely to be unique. This suggests that risk
assessments should be equally site-and source-specific to be effective.
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4. Exposure Route
There are two well documented exposure routes, inhalation of contamination aerosol and
aspiration of contaminated sources. Assessing aerosols as a potential inhalation route is complicated by
the lack of correlation between Legionella spp. concentration in contamination water and Legionella spp.
concentration in the air as a consequence of aerosol production [25]. This in part may be explained by
the differences in aerosol size generated by different water uses and the effect this has on Legionella spp.
transmission to the lower respiratory system [26]. In addition there may be substantial differences in
exposure from an aerosolized water droplet compared to a vesicles containing Legionella spp. expelled
from a protozoa. Depending on the host these vesicles can vary in size and the concentration of
Legionella spp. they contain [27,28].
In the instance of aspiration the volume of contaminated water entering the lung is determined by
the source and the susceptible person exposed [4,18,29]. It is clear that potable water is the principle,
if only, source of aspiration of contaminated water. Such devices as cooling towers and other remote
aerosol producing devices can therefore be ruled out as putative sources. More confounding is that
sources such as showers, basins, and spa pools are credible sources of aspiration of contaminated
water. At the same time they are equally credible sources of aerosol inhalation [18,29].
Clearly aspiration must be considered as the only route of exposure from some sources, such as
ice machines. Equally aerosol inhalation must be considered as the only route of exposure for other
sources. This is particularly true of cooling water systems. Case control studies have demonstrated
that cooling towers are a source of Legionnaire’s disease and can cause disease at considerable distance
from the source. In these instances, aerosol inhalation is the definitive exposure route [15,30].
5. Dose Response
Multiple factors must be considered in determining a dose response for Legionella. These include
the dose delivered, the virulence of the organism, and the susceptibility of the exposed population.
In the case of Legionnaires’ disease all three of these factors are not readily quantifiable.
5.1. Dose
Doses delivered by the aspiration route and aerosol inhalation route are not comparable.
Aspiration involves relatively large volume droplets of contaminated water entering the lung. Aerosol
inhalation requires very small volume droplets to enter the lungs. Arguably, aspirated droplets are
likely to have lower concentrations of cells per mL than aerosol in equivalent volumes. Conventional
thought is that concentration of cells in aerosol during travel is a contributing factor to disease. Travel
of aerosol results in concentration of the droplet contents. As a consequence the same volume of
droplets from a single source may contain different numbers of bacteria depending on whether they
are aerosolized or not [31]. If this is accepted, then aerosol introduces smaller volumes of more
concentrated cells per mL [29].
The disparity between volumes and concentrations and the behavior of aerosols in transit,
considering climatic influences, makes comparison with aspiration impossible. The issue of dose
becomes even more confused when considering sources in which both disease presentations may
occur [15]. In such cases calculating dose from a water body with a known concentration of infectious
cells per mL is not possible.
Recently, Strydom et al. [32] discussed dose response data for M. tuberculosis (TB) infections.
They concluded that there was ‘little benefit’ in applying QRMA to TB infections. This opinion
was based primarily on the uncertainty surrounding the measurable dose response of aerosolized
infectious particles.
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5.2. Virulence
Previous QMRA have mostly focused on ingestion of enteric pathogen; organisms with known
infectious doses and broad population responses. QMRA for Cryptosporidium exposure has clearly
identified the aggregate risks of exposure of a population to oocysts at different concentrations. In this
example the organism is an obligate water borne parasite with a known virulence. As such it lends
itself to a QMRA based risk assessment approach to managing risk [4].
Legionella spp. is an opportunist pathogen with a diverse range of species causing disease.
Virulence is widely variable within species and strains. Edelstein and Metlay [33] reported that there
are more than 400 different strains of L. pneumophila SG1 alone. Of these identified strains a minority
can cause disease.
Some current research has identified that virulence of a single strain varies depending on the
stage in the life cycle of the organism. It is clear that a single strain may be infectious or not dependent
upon the stage in a complex life cycle that includes 14 different developmental forms [34]. In addition,
replication within an amoeba host has been shown to increase L. pneumophila virulence [35]. This has
also been demonstrated for other opportunistic pathogens such as M. avium [36].
5.3. Animal Models of Exposure
Many studies used in developing QMRA for enteric pathogens have used human studies as
well as field estimates of exposure to establish both virulence and dose response. Clearly, exposure
of human subjects to infectious doses of Legionella spp. bacteria to establish a dose response is not
an ethically sound option. As a result, much of the data used for exposure models has been conducted
on animals under laboratory conditions [9,37]. In these investigations healthy but susceptible animal
species (guinea pigs) have been used as exposure models to controlled doses.
This introduces two confounding factors. Firstly, Legionnaires’ disease is widely accepted as
a disease of unhealthy individuals (immune-compromised). Secondly, it is also widely accepted that
humans are not particularly susceptible to infection. Infection is described as opportunistic [29].
Investigations have established that some animals are not susceptible to disease (mice) even at
high dose concentrations [38,39]. This data confirms the differences in susceptibility between species.
Similarities in cellular responses to Legionella spp. infection between mice and humans has also been
reported [39].
Interpolating the results of animal models using intrinsically susceptible species into human
exposure scenarios is therefore a major source of uncertainty. Using data from less susceptible species
(mice) would be more representative of real world dose responses. Regardless, the data would not
be able to represent dose response of an immune compromised sub-set of an otherwise resistant
(healthy) population.
Furthermore, animal models are based on exposure to aerosol in a carrier that optimizes lung
penetration. It is also reported that routes of exposure for these experiments were not consistent. Both
aerosol and intranasal routes of infection have been investigated [40,41]. Clearly this is not the case in
real world scenarios. Once again, these models, in some case deliberately, neglect aspiration as a mode
of infection [8].
5.4. Population Susceptibility
Disease incidence has reported ranges between 0.5 and 2+ notified cases per 100,000 across
different jurisdictions [42]. These incidences relate to the entire population. Disease incidence and
mortality rates are considerably higher in health care settings and other susceptible populations.
Predicting the susceptibility of a given population requires consideration of the demography of those
exposed, although gender (with males at greater risk) and age are consistent risk factors [18,42].
The literature identifies that Legionella spp. infections are for the most part opportunist. This may
not be true for Pontiac fever which may be a hypersensitivity in response to exposure rather than direct
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infection. Whether Pontiac fever is a disease associated solely with Legionella spp. remains in question.
Symptomatic similarities to exposure to other aerosolized gram negative bacteria are a documented
feature of disease [16,43].
In cases of Legionnaire’s disease a broad range of clinical presentations occur, ranging from mild
‘flu like symptoms to serious pneumonia. A determining factor in disease presentation is the immune
status of those exposed. Once again, this definition of susceptibility is very broad. Available data to
establish a DALY for Legionella spp. infection highlights the high mortality rate (Years of Life Lost,
YLL) in susceptible groups as the major contribution (92%) to the burden of disease [44]. This means
that the high mortality rate of a susceptible sub-set of the population skews the DALY calculation.
Inclusion of DALY data into QMRA is therefore statistically questionable.
Smokers are arguably the most susceptible demographic group. To date there is no available data
on the extent of smoking habits and the likelihood of infection. This leaves smoking as a ‘sliding scale’
of susceptibility.
Persons over 50 years old are another identified risk factor. This may be linked to the established
declining immune capability with age or to compounding age related health factors. There is no
current means of measuring the extent of immune competence in the aged.
Persons who are immune-compromised are also a high risk group. This range of susceptible
people encompasses a wide spectrum from cardiac patients to oncology and stem cell treatments.
Obviously, the level of susceptibility will be unique to the treatment and the recipient and will
remain incalculable.
An additional confounding factor is that in many instances the susceptibility of this
immune-compromised group to both aerosolization and aspiration is elevated. Swallowing disorders
linked to chemotherapies and neck surgery are accepted elevated risks for infection by aspiration [18].
In these scenarios the dose delivered by a given source cannot be separated between aspiration and
aerosolization of contaminated water containing the same number of organisms.
Neonates are also an identified high risk group. Documented infections via both aspiration and
inhalation routes have been reported [45–47].
Underlying lung disease is another risk factor that adds uncertainty. The inspiration and
expiration volumes of patients with chronic pulmonary obstruction disease (COPD) are extremely
variable. In any case the inspirational volume will be less than unaffected individuals. What this mean
in terms of dose inhalation and expiration is unclear. Whether less aerosol is inhaled, or less expired,
or residence time of contaminated water increases (all likely in COPD sufferers) will directly influence
what can be considered an infectious dose [48].
6. Exposure Frequency
Exposure frequency and duration resulting in disease is very much related to the exposure source.
Cooling towers and spa pools are established point sources of Legionnaires’ disease. In instances
where data is available it seems a single exposure to contaminated aerosol is sufficient to cause disease.
Duration of exposure is poorly documented but review of outbreaks from both sources suggests that
infection can result from less than an hour of either direct (physical contact with the source) or indirect
exposure (proximity to the source) [15,30,49].
In nosocomial settings the duration of exposure can be crudely defined by the length of stay of
the affected individual. However, the exposure frequency can be extremely variable ranging from
daily shower use to single use of a contaminated appliance. The nature of the appliance will dictate
it’s frequency of use and so determine the duration of exposure [50].
The uncertainties and data gaps necessary for a meaningful QMRA for Legionella spp. are tabulated
below. The table is based on the World Health Organization (WHO) schematic presented at Figure 1
above. The table highlights the persistent knowledge gaps that are unlikely to be resolved.
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7. Summary
QMRA has been a useful tool in assisting hazard analysis and critical control point (HACCP)-based
risk management programs for food processing and water utilities. It has assisted in providing
threshold-based acceptable limits for microbial contamination and source quality for these systems.
The considerable uncertainties associated with Legionella spp. infections (summarized in Table 1) make
it very difficult to capture quantitatively the nuances of human health risk associated with a diverse
population of sources, contaminants, exposure routes and susceptible populations.
Table 1. Summary of the uncertainties associated with Legionella Quantitative Microbial Risk
Assessment (QMRA).
Problem Formulation
What are the scope and purpose of the assessment?
What hazards? Legionella infections.
Which exposure
pathways?
Inhalation and/or aspiration of Legionella contaminated water from multiple
sources.
Which Health outcomes? Legionnaire’s disease in susceptible populations, Pontiac fever in general
populations.
What certainty is needed
for risk management?
This has not been quantified.
Exposure Assessment
What is the estimated dose of pathogens for the defined exposure pathway(s)?
Pathogen reduction Achieved by barriers/control measures and managing re-contamination
risks–well established control measures for most sources have been developed
and applied.
Source concentration Not defined as there are multiple sources. The relationship between source
concentration and exposure has not been quantified due to the diversity of
exposure scenarios. A robust and broadly applicable relationship between source
concentration and dose has not been quantified.
Magnitude and frequency
of exposure
Not quantifiable. Intermittent or occasional use of variable sources by different
demographic groups. Many and variable exposure scenarios have been
identified.
Health effects assessment
What are the expected health effects of the defined hazards?
Dose-response Not quantified in humans. Susceptibility is dependent on the host immune status.
Two principle routes of dose delivery exist.
Illness and sequalae In many cases none. Disease may be self-limited, profound, or fatal. Sequalae
range from minor to severe, prolonged and debilitating. Secondary transmission
is extremely rare.
Impact on disease burden DALY * for Years Lived with Disability (YLD) is low (8%). DALY for Years of Life
Lost is high (92%).
Risk characterization
What are the expected health effects of the estimated dose?
Quantification of risk Reported cases range from 0.5 to 5+: 100,000. Prevalence of disease is much




Not calculable for the range of infecting organisms, sources and exposure routes
on available evidence.
Sensitivity analysis Insufficient uncertainty data
* Disability Adjusted Life Years
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An argument for the use of QMRA is that it can be used to identify knowledge gaps and
uncertainties that can direct future investigations [6]. In the case of Legionella spp. infection the
knowledge gaps regarding contamination, consumption, dose-response and frequency of exposure
are likely to remain persistent and indeterminable. This is, in part, due to the opportunist nature of
Legionella spp. infections that dictate susceptibility and exposure as the major influences on health
outcomes. Combined with variable virulence and multiple sources, Legionella spp. infections pose
a different and more complex scenario than the relatively simple case of infection via ingestion of
pathogens of known virulence and measurable dose response.
It seems unlikely that a robust QMRA applicable to the broad range of infection scenarios can be
usefully derived and applied. The WHO [4] note that ‘it is not possible to consider all water-related
human pathogens in a QMRA’. Given the considerable uncertainty at every level of the process the
authors believe that the development of a QMRA for Legionella spp. is impractical. If this is the case,
then it is of little use in establishing the desired goals of informing a water safety risk management
plan [4].
Disease caused by other OWI with much more varied routes and sites of infection adds even
more complexity. It is worth noting that the majority of water transmitted diseases may be acquired
by routes other than ingestion or fecal-oral transmission [51–53]. The relatively simple example of
Legionella spp. as an OWI suggests that QMRA is prohibitively complex. If this is the case, then QMRA
for other OWIs with multiple routes of infection is an even less worthwhile proposition.
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